Absci · 3 months ago
Lead Clinical Trial Manager
Absci is a clinical-stage biotechnology company focused on advancing novel therapeutics using generative AI. They are seeking a Lead Clinical Trial Manager to oversee clinical research initiatives, manage operational aspects of clinical trials, and ensure compliance with regulatory standards across various therapeutic areas.
Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science
Responsibilities
Develop and maintain effective working relationships with cross-functional teams, external partners (CROs, vendors), and study sites to ensure collaboration and alignment on trial objectives
Manage Contract Research Organizations (CROs) to ensure that all clinical operations are carried out in alignment with the study’s goals, budget, and timelines
Ensure robust patient recruitment and retention strategies are in place and effectively executed
Author, review, and maintain Standard Operating Procedures (SOPs) related to clinical research and operations ensuring high quality, compliance with the study protocol and regulatory requirements across all trials
Support design, implementation, and oversight of clinical trials from concept through completion, ensuring adherence to protocols, regulatory requirements, and ethical standards
Identify potential risks and implement contingency plans
Ensure accurate data collection, documentation, and record-keeping
Support analysis and interpretation of clinical data, prepare reports, and communicate findings to internal stakeholders and regulatory agencies
Stay informed about industry developments, regulatory changes, and advancements in clinical research methodologies to inform trial design and execution strategies
Responsible for the integrity, confidentiality, and security of all research data
Qualification
Required
Bachelors Degree in life sciences, pharmacology or related field a must
Minimum of 2-3 years of experience in phase 1 clinical research and operations within the pharmaceutical or biotechnology industry, with experience in immunology and/or dermatology studies being a plus
Good working knowledge of Good Clinical Practice (GCP), FDA regulations, ICH guidelines, and other regulatory requirements in clinical research
Familiarity with the IND and CTA filing process
Exceptional organizational, communication, and leadership skills, with the ability to manage multiple projects and teams in a fast-paced environment
Strong analytical and problem-solving abilities, with a meticulous attention to detail
Demonstrated capability to work collaboratively across various departments and with external partners to achieve objectives
Ability to work in a fast-paced environment and manage multiple projects simultaneously
Ability to travel up to 20% per month as needed to oversee clinical trials at investigator sites, onsite meetings with vendors, and conferences
Preferred
Advanced degree (MSc., Ph.D., PharmD, MD) in life sciences, pharmacology, or related field preferred
Benefits
Competitive equity package applies.
In addition to equity, compensation packages include a wide range of medical, dental, and vision benefits.
The ability to participate in our employee stock purchase plan.
Absci offers highly competitive salaries and benefits, including medical, dental, vision insurance, unlimited vacation, parental leave, breakfast and lunch for onsite employees, employee assistance program, voluntary life and disability insurance, annual bonus potential, and 401(k) with a generous company match.
Company
Absci
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
H1B Sponsorship
Absci has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (3)
2023 (1)
2022 (3)
2021 (2)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$394.26MKey Investors
AMDMerck Global Health Innovation FundCasdin Capital
2025-07-24Post Ipo Equity· $50M
2025-01-08Post Ipo Equity· $20M
2024-02-27Post Ipo Equity· $86.4M
Recent News
2025-12-12
2025-12-11
2025-12-11
Company data provided by crunchbase